Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -18.39%69.92B | 3.81%356.34B | 12.64%98.73B | -7.22%85.57B | -2.42%86.38B | 14.41%85.67B | -6.03%343.27B | -4.36%87.65B | -11.92%92.22B | 10.21%88.52B |
Cost of revenue | -40.47%29.25B | 12.90%188.98B | 32.13%66.98B | -21.08%34.83B | -10.14%38.02B | 62.53%49.14B | -1.52%167.38B | 7.67%50.7B | -6.25%44.14B | 16.41%42.31B |
Gross profit | 11.32%40.66B | -4.84%167.37B | -14.08%31.75B | 5.51%50.73B | 4.65%48.36B | -18.18%36.53B | -9.95%175.89B | -17.07%36.96B | -16.56%48.09B | 5.09%46.21B |
Operating expense | -10.81%29.82B | 2.47%134.8B | 0.50%34.11B | 1.03%33.15B | -1.38%34.12B | 10.66%33.43B | -3.30%131.55B | -4.23%33.94B | -10.43%32.82B | 7.64%34.6B |
Staff costs | ---- | 13.71%38.56B | ---- | ---- | ---- | ---- | -5.40%33.91B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | -5.07%77.26B | ---- | ---- | ---- | ---- | -2.81%81.39B | ---- | ---- | ---- |
-Selling and marketing expense | ---- | 1.56%25.44B | ---- | ---- | ---- | ---- | -1.17%25.05B | ---- | ---- | ---- |
-General and administrative expense | ---- | -8.02%51.82B | ---- | ---- | ---- | ---- | -3.52%56.33B | ---- | ---- | ---- |
Depreciation and amortization | ---- | 28.50%3.69B | ---- | ---- | ---- | ---- | -8.85%2.87B | ---- | ---- | ---- |
-Depreciation | ---- | 28.50%3.69B | ---- | ---- | ---- | ---- | -8.85%2.87B | ---- | ---- | ---- |
Rent and land expenses | ---- | 4.86%3.17B | ---- | ---- | ---- | ---- | 1.20%3.03B | ---- | ---- | ---- |
Other operating expenses | ---- | 16.99%12.11B | ---- | ---- | ---- | ---- | 0.38%10.35B | ---- | ---- | ---- |
Operating profit | 250.06%10.85B | -26.55%32.57B | -177.95%-2.35B | 15.13%17.58B | 22.61%14.24B | -78.53%3.1B | -25.20%44.34B | -66.92%3.02B | -27.26%15.27B | -1.83%11.61B |
Net non-operating interest income (expenses) | 100.57%353M | 112.31%1.36B | 66.04%528M | 63.35%312M | 160.90%347M | 176M | 1,410.20%642M | 1,345.45%318M | 385.07%191M | 6,550.00%133M |
Non-operating interest income | 112.02%388M | 117.09%1.55B | 76.99%577M | 77.50%355M | 177.07%435M | 490.32%183M | 606.93%714M | 526.92%326M | 1,566.67%200M | 613.64%157M |
Non-operating interest expense | 400.00%35M | 159.72%187M | 512.50%49M | 377.78%43M | 266.67%88M | -77.42%7M | -52.00%72M | -73.33%8M | -88.61%9M | 20.00%24M |
Net investment income | -12.39%5.11B | -10.24%9.3B | 1,602.88%4.73B | 67.85%-3.23B | -72.23%1.97B | -55.30%5.84B | -1.18%10.37B | -96.24%278M | -567.72%-10.06B | 766.50%7.09B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -2,700.00%-156M | -245.70%-1.02B | 22.25%-552M | 158.82%484M | -186.04%-955M | -94.59%6M | -69.84%698M | -165.62%-710M | 249.60%187M | 23.20%1.11B |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 25.58%-32M | -607.55%-22.25B | -404.36%-21.98B | -113.44%-209M | -100.26%-19M | -230.77%-43M | 3,848.65%4.38B | -3,385.60%-4.36B | 4,473.53%1.56B | 1,622.01%7.2B |
Less:Other special charges | -25.58%32M | 599.12%22.24B | 412.72%21.97B | 113.44%209M | 100.26%19M | 258.33%43M | -1,925.45%-4.46B | 17,754.17%4.29B | -4,102.70%-1.56B | -1,605.69%-7.2B |
Less:Write off | ---- | -93.15%5M | -93.06%5M | ---- | ---- | --0 | -33.03%73M | -28.71%72M | --0 | --0 |
Other non-operating income (expenses) | -2,136.51%-1.28B | -1.91%-2.03B | -651.74%-1.9B | -384.21%-216M | 102.34%25M | 104.70%63M | -4.52%-1.99B | 117.67%344M | 744.44%76M | -11,955.56%-1.07B |
Income before tax | 62.41%14.84B | -69.31%17.94B | -1,833.78%-21.52B | 103.65%14.72B | -40.15%15.61B | -65.19%9.14B | -16.79%58.43B | -107.16%-1.11B | -68.57%7.23B | 86.49%26.08B |
Income tax | 48.82%4.21B | -67.18%3B | -142.61%-9.67B | 1,422.67%4.57B | 6.65%5.28B | -64.11%2.83B | -52.36%9.14B | -191.24%-3.99B | -95.11%300M | 35.90%4.95B |
Net income | 68.53%10.63B | -69.70%14.93B | -512.46%-11.85B | 46.53%10.15B | -51.12%10.33B | -65.66%6.31B | -3.42%49.29B | -74.29%2.87B | -58.91%6.93B | 104.33%21.13B |
Net income continuous operations | 68.51%10.63B | -69.70%14.93B | -512.32%-11.85B | 46.53%10.15B | -51.11%10.33B | -65.65%6.31B | -3.42%49.29B | -74.28%2.87B | -58.90%6.93B | 104.30%21.13B |
Noncontrolling interests | 0.00%5M | -4.55%21M | 0.00%6M | 150.00%5M | -50.00%5M | 25.00%5M | 29.41%22M | 50.00%6M | -60.00%2M | 150.00%10M |
Net income attributable to the company | 68.57%10.62B | -69.73%14.91B | -513.53%-11.86B | 46.52%10.15B | -51.12%10.32B | -65.68%6.3B | -3.43%49.26B | -74.33%2.87B | -58.92%6.92B | 104.32%21.12B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 68.57%10.62B | -69.73%14.91B | -513.53%-11.86B | 46.52%10.15B | -51.12%10.32B | -65.68%6.3B | -3.43%49.26B | -74.33%2.87B | -58.92%6.92B | 104.32%21.12B |
Gross dividend payment | ||||||||||
Basic earnings per share | 68.26%88.52 | -69.79%124.37 | -513.68%-98.91 | 46.33%84.58 | -51.21%86.09 | -65.72%52.61 | -3.56%411.62 | -74.39%23.91 | -59.00%57.8 | 104.00%176.46 |
Diluted earnings per share | 68.53%88.51 | -69.75%124.3 | -514.20%-98.91 | 46.55%84.56 | -51.15%86.05 | -65.72%52.52 | -3.53%410.93 | -74.38%23.88 | -58.99%57.7 | 104.13%176.16 |
Dividend per share | 0 | -69.35%38 | -75.44%28 | 0 | 0.00%10 | 0 | -3.88%124 | -4.20%114 | 0 | 0.00%10 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |